MARKET

TCMD

TCMD

Tactile Sys Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

38.10
-0.37
-0.96%
Closed 16:00 08/11 EDT
OPEN
39.04
PREV CLOSE
38.47
HIGH
40.16
LOW
37.82
VOLUME
304.65K
TURNOVER
--
52 WEEK HIGH
71.65
52 WEEK LOW
29.47
MARKET CAP
739.64M
P/E (TTM)
-86.0239
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TCMD stock price target is 63.80 with a high estimate of 70.00 and a low estimate of 55.00.

EPS

TCMD News

More
Tactile Medical to Present at the Canaccord Genuity 40th Annual Global Growth Conference
MINNEAPOLIS, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that managemen
GlobeNewswire · 6d ago
Tactile Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Tactile Systems Technology, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - August 4, 2020) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tactile Systems Technology, Inc. ("Tactile" or the "Company") (NASDAQ: TCMD).Faruqi & Faruqi LogoIf
Newsfile · 08/04 18:38
Tactile Systems Technology, Inc. (TCMD) Q2 2020 Earnings Call Transcript
Image source: The Motley Fool. Tactile Systems Technology, Inc. (NASDAQ: TCMD)Q2 2020 Earnings CallAug 3, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood evening, ladies and gentlemen, and
Motley Fool · 08/04 02:01
Tactile Systems Technology EPS misses by $0.49, misses on revenue
Tactile Systems Technology (NASDAQ:TCMD): Q2 GAAP EPS of -$0.72 misses by $0.49. Revenue of $35.12M (-22.3% Y/Y) misses by $1.91M. Press Release
seekingalpha · 08/04 01:14
Tactile Systems Technology (TCMD) Reports Q2 Loss, Misses Revenue Estimates
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 16.00% and -6.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/03 23:15
Tactile Systems Tech Q2 EPS $(0.72) May Not Compare To $(0.22) Estimate, Sales $35.10M Miss $36.90M Estimate
Tactile Systems Tech (NASDAQ:TCMD) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.22) by 227.27 percent. This is a 614.29 percent decrease over earnings of $0.14 per
Benzinga · 08/03 20:25
Tactile Systems Technology, Inc. Reports Second Quarter 2020 Financial Results
Second Quarter Revenue Decreased 22% Year-Over-Year; Decreased 20% Year-Over-Year on an Operational Basis First Half Revenue Decreased 5% Year-over-Year; Flat Year-over-Year on an Operational BasisMINNEAPOLIS, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Tactile Systems
GlobeNewswire · 08/03 20:05
WeissLaw LLP: Tactile Systems Technology, Inc. is the Subject of a Legal Investigation
WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York, California and Georgia, announces an investigation of Tactile Systems Technology, Inc. (NASDAQ: TCMD) ("Tactile Systems," or the "Company").
PR Newswire · 07/30 01:46

Industry

Medical Equipment, Supplies & Distribution
-0.66%
Healthcare Equipment & Supplies
-0.63%

Hot Stocks

Symbol
Price
%Change

About TCMD

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.
More

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TCMD stock methods without spending real money on the virtual paper trading platform.